Bibliographic Info
GuidelineConsolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
Year of Publication2016
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
Moderate
For localized non-meningeal disease, or in patients with isolated serum CrAg positivity (where active cryptococcal meningitis has been excluded). Fluconazole 800 mg/day (or 12 mg/kg/ day if below 19 years) for two weeks, then 400 mg/day (or 6 mg/kg/day up to 400–800 mg/ day if below 19 years) for 8 weeks, and continued maintenance with fluconazole 200 mg/day is recommended. The optimal antifungal regimen in this population remains to be determined
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Rapid advice : diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children
Year2011
InstitutionWorld Health Organization